CAN IMMUNE CHECKPOINT INHIBITORS BE SAFELY USED IN PATIENTS WITH MALIGNANCY AND SEVERE DERMATOMYOSITIS?

被引：0
|
作者：
Pietsch, David [1 ]
Bigby, Kieron [2 ]
Hennessey, Ashleigh [1 ]
机构：
[1] Royal Brisbane Womens Hosp, Dept Rheumatol, Herston, Qld, Australia
[2] Redcliffe Hosp, Dept Med Oncol, Redcliffe, Qld, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P68
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [1] Can Immune Checkpoint Inhibitors Safely Combat Cancer in Patients with Rheumatoid Arthritis?
    Ibis, Betul
    Bahar, Furkan
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 423 - 424
  • [2] Immune checkpoint inhibitors in malignancy
    Ardolino, Luke
    Joshua, Anthony
    AUSTRALIAN PRESCRIBER, 2019, 42 (02) : 62 - 67
  • [3] OUTCOMES OF IMMUNE CHECKPOINT INHIBITOR THERAPY IN MALIGNANCY-ASSOCIATED DERMATOMYOSITIS
    Fernandez, D. R.
    Thaler, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (02) : 559 - 559
  • [4] Safety of immune checkpoint inhibitors in patients with advanced malignancy complicated with rheumatoid arthritis
    Kudo, Keita
    Nakajima, Saki
    Uejima, Shigeya
    Horiuchi, Tetsuya
    Nakanishi, Fumihiko
    Utunomiya, Takuhide
    Kakiuchi, Mai
    Yamaguchi, Mami
    Ohshima, Shiro
    ANNALS OF ONCOLOGY, 2021, 32 : S301 - S301
  • [5] Analysis of immune-related adverse events in gastrointestinal malignancy patients treated with immune checkpoint inhibitors
    Niu, Chengu
    Zhu, Kaiwen
    Zhang, Jing
    Joshi, Utsav
    Liu, Hongli
    Zahid, Salman
    Jadhav, Nagesh
    Okolo, Patrick I.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1261 - 1271
  • [6] ANTI-TIF1-G POSITIVE DERMATOMYOSITIS WITH SEVERE OROPHARYNGEAL INVOLVEMENT AFTER IMMUNE CHECKPOINT INHIBITORS
    Tonutti, A.
    Luciano, N.
    Ceribelli, A.
    Sonaglia, A.
    Renna, D.
    Repici, A.
    Lania, A.
    Lleo, A.
    De Nicola, S.
    Bussini, L.
    Morelli, P.
    Pagani, M.
    Selmi, C.
    De Santis, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 558 - 558
  • [7] Enoxaparin can be used safely in patients with severe thrombocytopenia due to intensive chemotherapy regimens
    Herishanu, Y
    Misgav, M
    Kirgner, I
    Ben-Tal, O
    Eldor, A
    Naparstek, E
    LEUKEMIA & LYMPHOMA, 2004, 45 (07) : 1407 - 1411
  • [8] Can Tumor Necrosis Factor Inhibitors Be Safely Used in Pregnancy?
    Ali, Yaser M.
    Kuriya, Bindee
    Orozco, Catalina
    Cush, John J.
    Keystone, Edward C.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 9 - 17
  • [9] Can succinylcholine be used safely in hyperkalemic patients?
    Schow, AJ
    Lubarsky, DA
    Olson, RP
    Gan, TJ
    ANESTHESIA AND ANALGESIA, 2002, 95 (01): : 119 - 122
  • [10] CHARACTERIZING SEVERE ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Chen, Chung-Jiah
    Kim, Lisa
    Weaver, Ashley
    Patel, Sandip
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A383 - A384
12345